Loading clinical trials...

COMPLETEDPhase 2NCT04563923

Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody

The development of Auto Immune bullous Diseases (AIBD) results from a complex interaction between innate and adaptive immune systems. Bullous pemphigoid (BP), the most frequently encountered AIBD, pre...

Lead sponsor: Centre Hospitalier Universitaire de Nice•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417 · Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), and more

RECRUITING

Autoimmune Blistering Diseases Study

NCT02753777 · Pemphigus Vulgaris, Pemphigus Foliaceus, and more

COMPLETEDPhase 4

Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid

NCT05984381 · Bullous Pemphigoid

Approved For Marketing

Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

NCT05906706 · Bullous Pemphigoid

TERMINATEDPhase 3

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

NCT04612790 · Bullous Pemphigoid

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment15

Start dateOct 2020

Last updatedApr 12, 2024

Condition

Bullous Pemphigoid

Locations shown

CHU de Nice- Dermatologie

Nice, Alpes-Maritimes

APHM, Timone

Marseille, Bouche Du Rhône

APHM, Hôpital Nord

Marseille, Bouches Du Rhône

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2024Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions